Programme
| 08:00 | Registration Opens | DKMS 08:00-09:00 Closed Session 09:00-12:30 Open Session |
| 09:00-10:00 | SYMPOSIUM DR REDDY’S Topic: Update on NPC Speaker: tbc |
|
| Session 1: Joint Plenary : Diagnostics in Cancer Chairs: Georgia and Estelle |
||
| 10:20-10:30 | Opening Dr Devan Moodley and Dr Justin Du Toit |
|
| 10:30-11:00 | Liquid biopsies in 2026 Speaker: Dr Kusha Kalideen |
|
| 11:00-11:30 | The place of genetic testing in cancer Speaker: tbc |
|
| 11:30-12:00 | Risk Adapted therapy in EBC Speaker: Dr William Audeh |
|
| 12:00-12:30 | The molecular footprint of cytotoxic therapies Speaker: Rachel Viava |
|
| 12:30-13:30 | LUNCH | |
| 12:30-13:20 | SYMPOSIUM : ASTRA ZENECA Topic: HER2 Speaker: tbc |
|
| 13:30-15:30 | Session 2: Breast Track Chairs: tbc |
Session 2: Optimising the Recipient Chairs: Dr Justin Du Toit & Dr Candice Hendricks |
| 13:30-14:00 | Topic: CDK4/6i in EBC What when and whom? Speaker: tbc |
Topic: Model-based dosing of ATG for better survival after allo transplantation Speaker: Professor Jan Jaap de Boelens Chief of the Paediatric Transplant and Cellular Therapy Service (TCT) at Memorial Sloane Kettering, New York, Sponsored by DKMS |
| 14:00-14:30 | Topic: ADC,s in BC. Where is it best used? Speaker: tbc |
Topic: Transplant conditioning intensity (TCI) score predicts allo-HCT outcomes in patients with myelofibrosis Dr Donal McLornan University college London, UK |
| 14:30-15:00 | Case 1: 1 EBC 1 MBC Case presenter 10 min Discussant 10 min Q and A 10 min |
Topic: How much HLA still matters in allo-SCT? Speaker: tbc Sponsored by: DKMS sponsored . |
| 15:00-15:30 | Case 2: 1 EBC 1 MBC Case presenter 10 min Discussant 10 min Q and A 10 min |
Topic: Haplo SCT strategies in resource limited settings Speaker: Dr Mohana Reddy Sankalp foundation, India Sponsored by: DKMS |
| 15:30-16:00 | REFRESHMENT BREAK | REFRESHMENT BREAK |
| 16:00-16:30 | Topic: What’s new in Her2 amplified disease? Speaker: tbc |
Topic: ‘real world’ experience of JAK inhibitors, splenomegaly management and novel agents in myelofibrosis transplant Speaker: Dr Donal McLornan UCL, London |
| 16:30-17:00 | Topic: Optimal management of the Her2 low patient Speaker: tbc |
Topic: (GRAPPA) Graft vs host disease prophylaxis in MUD allo: a RCT comparing PTCy vs ATG Speaker: Dr Judith Schaffrath Martin Luther University Halle-Wittenberg, Germany Sponsored by DKMS |
| 17:00-18:00 | Case 1: Her2 positive 1 Her2 low Case presenter 10 min Discussant 10 min Q and A 10 min |
Topic: Paediatric B-cell Acute lymphoblastic leukaemia, use of Blincyto Speaker: tbc |
| Case 2: Her2 positive 1 Her2 low Case presenter 10 min Discussant 10 min Q and A 10 min |
Topic: Disease risk but not remission status determines transplant outcomes in AML: long-term outcomes of the ASAP trial Speaker: Dr Judith Schaffrath [Martin Luther University Halle-Wittenberg, Germany] Sponsored by DKMS |
|
| 18:00-18:30 | SASMO AGM | SASCeTS AGM |
| 18:30-21:30 | Exhibitors Welcome | Networking Cocktail | |
| 07:00 | Registration & Exhibition Opens | |||||||
| 07:00-07:50 | SYMPOSIUM : NOVARTIS
Topic: tbc Speaker: tbc |
|||||||
| Session 3: Joint Plenary
Chairs: tbc |
||||||||
| 07:50-08:00 | Opening of Plenary | |||||||
| 08:00-08:30 | Honorary lecture Speaker: tbc |
|||||||
| 08:30-09:00 | A bone marrow transplant registry for South Africa? Speaker: Prof Estelle Verburgh |
|||||||
| 09:00-09:30 | Essentials of setting up research units in SA? Prof Paul Ruff |
|||||||
| 09:30-10:00 | Fertility Lecture Speaker: tbc |
|||||||
| 10:00-10:50 | REFRESHMENT BREAK | |||||||
| 10:00-10:50 | SYMPOSIUM J & J Topic: Prostate Speaker: tbc |
SYMPOSIUM ASTRA ZENECA Topic: Eculizumab in thrombotic micro-angiopathy post-transplant Speaker: Dr Regis da Latour, Paris, France Chair: Dr Justin Du Toit |
||||||
| 10:50-13:20 | Session 4: | |||||||
| SASMO | SASCETS | SASOPh – PHARMACISTS | SASREG | NURSES SYMPOSIUM |
||||
| Session 4: Uro Genital Track Chairs: tbc |
Session 4: Donor track Chairs: Dr Hannes Koornhof, Dr Pieter du Toit |
|||||||
| 10:50-11:20 | Topic: The latest developments in the treatment of metastatic Renal Cell Carcinoma. Speaker: Prof Manuela Schmidinger |
Topic: Donor selection beyond HLA: focus on donor age Speaker: Prof. Dr Tobias Holderried Bonn, Germany Sponsored by: DKMS |
||||||
| 11:20-11:50 | Topic: Ovarian speaker PARP Speaker: tbc |
Topic: Allo-HCT in Sickle cell disease Speaker: Julie Makani, Tanzania Sponsored by DKMS |
||||||
| 11:50-13:00 | Topic: Challenging cases in UGT Presenters: Moderator & 4 panelists |
Topic: Optimising donor outcomes Speaker: Jay Feinberg CEO, of Gift of Life Marrow Registry, New York Sponsored by SABMR |
||||||
| Topic: Duffy agnostic decision making (donors) Speaker: Tanya Glatt |
||||||||
| 13:00-14:00 | LUNCH | |||||||
| 13:00-13:50 | SYMPOSIUM – ROCHE Topic: HER 2 Patient Focus: What is important to a patient with HER 2 EBC In South Africa? Speaker: tbc |
SYMPOSIUM J& J Topic: Myeloma Speaker: Prof Roberta Mina |
||||||
| 14:00-17:00 | Session 5: | |||||||
| SASMO Lung Chairs: tbc |
SASCETS Cell & Gene Therapy SA Chairs: Dr Sharlene Parasnath Dr Jacques Malherbe |
SASOPh – PHARMACISTS |
SASREG | NURSES SYMPOSIUM |
||||
| 14:00-14:30 | Topic: Rare Lung Cancer Mesothelioma Thymic NET Speaker: tbc |
Topic: CAR-NK cells (immunity Bio) Speakers: Lennie Sender & Jackie Thomson |
||||||
| 14:30-15:00 | Topic: The evolution of lung cancer treatment Speaker: Dr Lizza Hendricks Netherlands |
Topic: Access to CGT in SA Speaker: C. Hendricks Topic: CAR T cell trial ACTLife. Speaker: D. Brittain |
||||||
| 15:00-15:30 | Panel Discussion Topic: How to improve lung cancer care in Africa |
|||||||
| 15:30-16:00 | REFRESHMENT BREAK | |||||||
| 16:00-18:00 | Session 6: Innovation in Oncology | |||||||
| Chairs: tbc | Chairs: Dr Justin du Toit Dr Jackie Thomson |
|||||||
| 16:00-16:30 | Topic: Skin cancer Speaker: Dr Teresa Amaral |
Topic: ATT progress in South Africa Speaker: Elke Neujahr, CEO DKMS |
||||||
| 16:30-17:00 | Topic: Innovation in Cancer Treatment Speaker: tbc |
Topic: Allo-HCT for children with inborn errors Speaker: Prof Michael Albert , DKMS, Germany |
||||||
| 17:00-18:00 | Proffered papers | Proffered papers | ||||||
| 19:30-22:30 | CONFERENCE DINNER | |||||||
| Session 7: Joint Plenary Chairs: |
|||
| 08:30-08:40 | Opening | ||
| 08:40-09:00 | Bottle necks in Oncology care Speaker: tbc |
||
| 09:00-09:30 | AI in Oncology Speaker: Dr Hemmel Amrania |
||
| 09:30-10:00 | VZV Vaccinations in Oncology patients Speaker: Dr Jeremy Nel |
||
| 10:00-11:00 | REFRESHMENT BREAK | ||
| 10:00-10:50 | SYMPOSIUM ROCHE Topic: Shifting the paradigm in the management of lung cancer, from addressing early-stage disease to considering the patient journey in extensive-stage lung cancer. Speaker: tbc |
SYMPOSIUM GSK Topic: V Vaccines post-haematopoietic transplant Speaker: Dr Jeremy Nel |
|
| 11:00-12:00 | SASMO Session 8: Female Genital track Chairs: tbc |
SASCeTS: Session 8: Pre Tx Optimisation & Post Transplant Complications Chairs: Prof Estelle Verburgh, Dr David Brittain |
|
| 11:00-11:30 | Topic: Ovarian Cancer Speaker: tbc |
Topic: Belumosudil use for chronic GVHD Speaker: Professor Jan Jaap de Boelens, MSK, NY, USA Sponsored by DKMS |
|
| 11:30-12:00 | Topic: Endometrial Cancer Spaker: tbc |
Topic: Transfusion medicine topic Speaker: Professor Matt Seftel, Canadian Blood Service Sponsored by SASCETS |
|
| 12:00 | Close | Close | |